Benvic has acquired US-based Chemres, a provider of polymers, custom compounds and solutions for a variety of industries including medical. 

Chemres’ compounding and distribution facility in Chesapeake, Virginia, USA

Headquartered in Princeton (New Jersey) and with operations in Chesapeake (Virginia), Chemres is a specialty compounder with a strong position in the US contact lens market and has long-term customer relationships in the medical, wire & cable, and packaging industries. The company also provides logistical and supply chain management expertise.

The combination with Chemres will allow Benvic to enter the US market and strengthen its exposure to the medical sector, allowing Benvic to become a key global supplier in this market. Benvic will combine its track record of supplying highly innovative solutions with the expertise of Chemres in the North American marketplace and its strong customer portfolio.

The acquisition of Chemres is the ninth ‘add-on’ acquisition since Benvic joined Investindustrial’s portfolio in 2018. Among the others, in 2019 Benvic acquired Modenplast Medical, an Italian compounder, specialising in medical-grade vinyl compounds and tubing extrusion. This was followed in 2020 with the acquisition of Luc & Bel, an Italian manufacturer which specialises in designing and manufacturing medical device components, and in 2021 with the acquisition of selected TPE and PP compounding assets from Celanese.

The management team of Chemres, led by Chemres’ founder Paul Keimig, is partnering with Benvic to lead Benvic’s growth in North America.

Luc Mertens, CEO of Benvic Group, said: “We look forward to work closely with the management team of Chemres in the coming years to expand our operations in North America and grow our polymer expertise across sectors and in particular in the medical sector."

Part of Rapid News Group

© 2021 Rapid Life Sciences Ltd. A Rapid News Group Company. All Rights Reserved